Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of VEGFR2 and FGFR1 identified by BMS scientists

March 18, 2004

Aloxi incorporated in NCCN antiemetic guidelines for CINV

March 18, 2004

TopoTarget and deCODE collaborate on improved cancer treatments

March 18, 2004

Targeting telomerase for multiple myeloma therapy

March 18, 2004

Submission of final section of Onco TCS rolling NDA

March 17, 2004

European approval for Faslodex

March 17, 2004

XL-119 receives orphan drug status for bile duct tumors

March 17, 2004

FDA Advisory Committee sets date to review RSR-13 NDA

March 17, 2004

New alphav integrin inhibitors and their use reported by Sigma-Tau

March 17, 2004

Biomar presents a novel cytotoxic agent isolated from fungal cultures

March 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...